Monsenso appoints COO Nanna Iversen to executive management

11.9.2023 17:15:01 CEST | Monsenso | Chang. board/management/certified advisors

Company announcement no. 13-2023

Copenhagen, 2023.09.11

“This message includes inside information”

Monsenso - a leading provider of digital health solutions for mental health and chronic disorders – is strengthening its executive management by appointing COO Nanna Iversen to join the management.

Nanna Iversen has been with Monsenso for the last seven years in different leadership positions and has since 2020 served as our Chief Operating Officer (COO). She has been instrumental in all aspects of our operations over the last years including customer and research project implementations, customer and project support, product development as well as regulatory compliance. 

Thomas Lethenborg commented: ”We are happy to be able to include Nanna Iversen in the executive management. Her hands-on experience from all disciplines and processes at Monsenso combined with her previous international experiences from other businesses will be valuable for us as we set the direction for our continued growth following our recent large project- and customer wins”.

With the announcement, the executive management consist of CEO Thomas Lethenborg and COO Nanna Iversen.

 

Any inquiries regarding this notice should be directed to:

Monsenso

CEO
Thomas Lethenborg
Tel. [phone]
E-mail: [e-mail] 

Chairman of the board
Peter Mørch Eriksen
Tel. [phone]
E-mail: [e-mail]

Certified Adviser

Norden CEF A/S
John Norden

E-mail: [e-mail]

About Monsenso

Monsenso is an innovative technology company offering a digital health solution for mental health and behavioral disorders. Our mission is to help provide better mental health to more people at lower costs. Our solution helps optimise the treatment of mental disorders and gives a detailed overview of an individual’s mental health through the collection of outcome, adherence and behavioural data. It connects individuals, carers and health care providers to enable personalised treatment, remote care and early intervention. Based on continuous research and development, our team is committed to developing solutions that fit seamlessly into the lives of individuals, increase their quality of life and improve the efficacy of mental health treatment. To learn more visit www.monsenso.com

Attachments

• Download announcement as PDF.pdf

© Ritzau Denmark, source Ritzau English Regulatory Releases